Verum Partners LLC Merck & Co., Inc. Transaction History
Verum Partners LLC
- $310 Billion
- Q2 2024
A detailed history of Verum Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Verum Partners LLC holds 3,440 shares of MRK stock, worth $439,494. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,440
Previous 3,464
0.69%
Holding current value
$439,494
Previous $457 Million
6.83%
% of portfolio
0.14%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding MRK
# of Institutions
3,771Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$31.1 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.4 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$15 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$11 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.21 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $324B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...